MedPath

Lidocaine Hydrochloride

Lidocaine Hydrochloride Topical Solution, USP Rx only

Approved
Approval ID

ffb2d794-2c88-48a2-beff-d01b6fcea51f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 25, 2022

Manufacturers
FDA

Novitium Pharma LLC

DUNS: 080301870

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70954-518
Application NumberANDA216250
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lidocaine Hydrochloride
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 25, 2022
FDA Product Classification

INGREDIENTS (4)

LIDOCAINE HYDROCHLORIDEActive
Quantity: 40 mg in 1 mL
Code: V13007Z41A
Classification: ACTIR
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine Hydrochloride - FDA Drug Approval Details